
### [MONDO:0020027](http://purl.obolibrary.org/obo/MONDO_0020027)
**Label:** rare allergic disease

**Subclasses:** [MONDO:0015554](http://purl.obolibrary.org/obo/MONDO_0015554) (Typical urticaria pigmentosa), [MONDO:0017853](http://purl.obolibrary.org/obo/MONDO_0017853) (hypersensitivity pneumonitis), [MONDO:0015556](http://purl.obolibrary.org/obo/MONDO_0015556) (nodular urticaria pigmentosa), [MONDO:0019315](http://purl.obolibrary.org/obo/MONDO_0019315) (diffuse cutaneous mastocytosis), [MONDO:0015555](http://purl.obolibrary.org/obo/MONDO_0015555) (plaque-form urticaria pigmentosa), [MONDO:0018304](http://purl.obolibrary.org/obo/MONDO_0018304) (Schnitzler syndrome), [MONDO:0019316](http://purl.obolibrary.org/obo/MONDO_0019316) (Maculopapular cutaneous mastocytosis), [MONDO:0019314](http://purl.obolibrary.org/obo/MONDO_0019314) (cutaneous mastocytoma), [MONDO:0015055](http://purl.obolibrary.org/obo/MONDO_0015055) (acquired angioedema type 2), [MONDO:0015056](http://purl.obolibrary.org/obo/MONDO_0015056) (acquired angioedema type 1), [MONDO:0019576](http://purl.obolibrary.org/obo/MONDO_0019576) (telangiectasia macularis eruptiva perstans), [MONDO:0015057](http://purl.obolibrary.org/obo/MONDO_0015057) (Renin-angiotensin-aldosterone system-blocker-induced angioedema), [MONDO:0019298](http://purl.obolibrary.org/obo/MONDO_0019298) (rare urticaria), [MONDO:0019013](http://purl.obolibrary.org/obo/MONDO_0019013) (non-histaminic angioedema), [MONDO:0020028](http://purl.obolibrary.org/obo/MONDO_0020028) (rare allergic respiratory disease), [MONDO:0007969](http://purl.obolibrary.org/obo/MONDO_0007969) (Melkersson-Rosenthal syndrome), [MONDO:0020537](http://purl.obolibrary.org/obo/MONDO_0020537) (occupational allergic alveolitis), [MONDO:0019624](http://purl.obolibrary.org/obo/MONDO_0019624) (acquired angioedema), [MONDO:0017244](http://purl.obolibrary.org/obo/MONDO_0017244) (pseudoxanthomatous diffuse cutaneous mastocytosis), [MONDO:0015340](http://purl.obolibrary.org/obo/MONDO_0015340) (drug rash with eosinophilia and systemic symptoms), [MONDO:0017243](http://purl.obolibrary.org/obo/MONDO_0017243) (bullous diffuse cutaneous mastocytosis), [MONDO:0008353](http://purl.obolibrary.org/obo/MONDO_0008353) (Pruritic urticarial papules and plaques of pregnancy), [MONDO:0015243](http://purl.obolibrary.org/obo/MONDO_0015243) (allergic bronchopulmonary aspergillosis), [MONDO:0019023](http://purl.obolibrary.org/obo/MONDO_0019023) (cutaneous mastocytosis), [MONDO:0017363](http://purl.obolibrary.org/obo/MONDO_0017363) (idiopathic chronic eosinophilic pneumonia), [MONDO:0020534](http://purl.obolibrary.org/obo/MONDO_0020534) (farmer's lung disease), [MONDO:0020535](http://purl.obolibrary.org/obo/MONDO_0020535) (House allergic alveolitis), [MONDO:0020536](http://purl.obolibrary.org/obo/MONDO_0020536) (pigeon-breeder lung disease), [MONDO:0007776](http://purl.obolibrary.org/obo/MONDO_0007776) (hypersensitivity pneumonitis, familial), [MONDO:0013766](http://purl.obolibrary.org/obo/MONDO_0013766) (familial cold autoinflammatory syndrome 3), [MONDO:0014218](http://purl.obolibrary.org/obo/MONDO_0014218) (severe dermatitis-multiple allergies-metabolic wasting syndrome), 

**Corr. equiv. classes:** [Orphanet:100056](http://www.orpha.net/ORDO/Orphanet_100056), [Orphanet:100057](http://www.orpha.net/ORDO/Orphanet_100057), [Orphanet:37748](http://www.orpha.net/ORDO/Orphanet_37748), [Orphanet:31740](http://www.orpha.net/ORDO/Orphanet_31740), [Orphanet:280794](http://www.orpha.net/ORDO/Orphanet_280794), [Orphanet:100055](http://www.orpha.net/ORDO/Orphanet_100055), [Orphanet:158772](http://www.orpha.net/ORDO/Orphanet_158772), [OMIM:103920](http://purl.obolibrary.org/obo/OMIM_103920), [Orphanet:99907](http://www.orpha.net/ORDO/Orphanet_99907), [Orphanet:139402](http://www.orpha.net/ORDO/Orphanet_139402), [Orphanet:99908](http://www.orpha.net/ORDO/Orphanet_99908), [Orphanet:99909](http://www.orpha.net/ORDO/Orphanet_99909), [Orphanet:66646](http://www.orpha.net/ORDO/Orphanet_66646), [Orphanet:2902](http://www.orpha.net/ORDO/Orphanet_2902), [Orphanet:64745](http://www.orpha.net/ORDO/Orphanet_64745), [Orphanet:2483](http://www.orpha.net/ORDO/Orphanet_2483), [Orphanet:99906](http://www.orpha.net/ORDO/Orphanet_99906), [Orphanet:658](http://www.orpha.net/ORDO/Orphanet_658), [OMIM:615508](http://purl.obolibrary.org/obo/OMIM_615508), [OMIM:145300](http://purl.obolibrary.org/obo/OMIM_145300), [Orphanet:91385](http://www.orpha.net/ORDO/Orphanet_91385), [Orphanet:79455](http://www.orpha.net/ORDO/Orphanet_79455), [Orphanet:79456](http://www.orpha.net/ORDO/Orphanet_79456), [Orphanet:79457](http://www.orpha.net/ORDO/Orphanet_79457), [Orphanet:158769](http://www.orpha.net/ORDO/Orphanet_158769), [Orphanet:300359](http://www.orpha.net/ORDO/Orphanet_300359), [Orphanet:98052](http://www.orpha.net/ORDO/Orphanet_98052), [Orphanet:369992](http://www.orpha.net/ORDO/Orphanet_369992), [Orphanet:280785](http://www.orpha.net/ORDO/Orphanet_280785), [Orphanet:158766](http://www.orpha.net/ORDO/Orphanet_158766), [OMIM:178995](http://purl.obolibrary.org/obo/OMIM_178995), [Orphanet:90389](http://www.orpha.net/ORDO/Orphanet_90389), [OMIM:155900](http://purl.obolibrary.org/obo/OMIM_155900), [OMIM:300909](http://purl.obolibrary.org/obo/OMIM_300909), [Orphanet:1164](http://www.orpha.net/ORDO/Orphanet_1164), [OMIM:614468](http://purl.obolibrary.org/obo/OMIM_614468), [Orphanet:79384](http://www.orpha.net/ORDO/Orphanet_79384), 

**Class expressions from DL-Learner:**

- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 27.90%
- Thing 27.89%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 27.89%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 25.06%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) 24.03%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 23.20%
- [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 22.75%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 21.00%
- [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 20.94%
- [HP:0001881](http://purl.obolibrary.org/obo/HP_0001881) (Abnormality of leukocytes) 20.31%
- [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) 20.30%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 17.65%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 17.65%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) 17.40%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 16.55%


